GlassScriptPhysician profile
Patrick Andrew Huddleston
NPI 1477908291
$4,673.12
in general payments reported to CMS, 2019-2025
25 companies · $1,052 in 2025
The $1,052 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2021: $212 · 2022: $376 · 2023: $324 · 2024: $2,553 · 2025: $1,052.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,902 · Travel and Lodging: $1,177 · Consulting Fee: $850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,901.82 |
| Travel and Lodging | $1,177.00 |
| Consulting Fee | $850.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,677.85 | 2022-2024 | Aquabeam System |
| Stryker Corporation | $850.00 | 2024-2025 | |
| Boston Scientific Corporation | $452.46 | 2019-2024 | Rezum Generator, Lithovue |
| Urogen Pharma, INC. | $281.30 | 2022-2025 | Jelmyto |
| Janssen Biotech, INC. | $168.82 | 2021-2024 | Erleada, Akeega |
| Astellas Pharma US INC | $166.42 | 2021-2023 | Myrbetriq |
| Axonics, INC. | $166.36 | 2022-2024 | Bulkamid, Axonics |
| Endo USA, INC. | $130.85 | 2024-2025 | Xiaflex, Aveed |
| Olympus America INC. | $118.34 | 2024-2025 | Itind System |
| Blue Earth Diagnostics | $116.07 | 2021-2024 | |
| Pfizer INC. | $79.41 | 2021-2024 | |
| Endo Pharmaceuticals INC. | $77.83 | 2022-2023 | Aveed, Xiaflex |
| Myriad Genetic Laboratories, INC. | $55.14 | 2023-2025 | Prolaris |
| Merck Sharp & Dohme LLC | $54.03 | 2024 | Lynparza, Keytruda |
| Progenics Pharmaceuticals, INC. | $45.21 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $38.63 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Immunitybio, INC. | $34.88 | 2025 | |
| Calyxo, INC. | $32.34 | 2025 | Cvac Aspiration System |
| Sumitomo Pharma America, INC. | $24.27 | 2023 | Orgovyx |
| Tolmar, INC. | $19.29 | 2025 | Eligard, Jatenzo |
| Novartis Pharmaceuticals Corporation | $19.09 | 2025 | |
| Accord Healthcare, INC. | $17.93 | 2024 | |
| Azurity Pharmaceuticals, INC. | $17.79 | 2025 | Azmiro |
| Medtronic, INC. | $15.78 | 2024 | Interstim |
| Kowa Pharmaceuticals America, INC. | $13.03 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Huddleston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.